Log OR (95% CI) | OR (95% CI) | p-value | |
---|---|---|---|
Model 1 | |||
N training = 491, N evaluation = 211 | |||
Gender (female) | 0.14 [-0.49-0.78] | 1.15 [0.61–2.17] | 0.66 |
Age (years) | 0.02 [0.0-0.04] | 1.02 [1.00-1.04] | 0.07 |
Body weight (kg) | -0.15 [-0.32-0.02] | 0.86 [0.72–1.02] | 0.09 |
Height (cm) | 0.14 [-0.03-0.32] | 1.16 [0.97–1.38] | 0.11 |
Body mass index (kg/m2) | 0.46 [-0.07-1] | 1.59 [0.93–2.71] | 0.09 |
Days after start of COVID-19 symptoms | 0.02 [0.01–0.02] | 1.02 [1.01–1.02] | < 0.001 |
COVID-19 symptoms duration (days) | 0.01 [-0.02-0.03] | 1.01 [0.98–1.03] | 0.53 |
Model 2 (univariate logistic regression) | |||
N training = 590, N evaluation = 254 | |||
Abbott quantitative SARS-CoV-2 Ab test (100 BAU/ml) | 0.41 [0.33–0.50] | 1.51 [1.38–1.64] | < 0.001 |
Model 3 | |||
N training = 590, N evaluation = 254 | |||
Abbott quantitative SARS-CoV-2 Ab test (100 BAU/ml) | 0.37 [0.28–0.46] | 1.44 [1.32–1.58] | < 0.001 |
Vaccination | 0.97 [0.14–1.8] | 2.64 [1.15–6.04] | 0.02 |
Model 4 | |||
N training = 420, N evaluation = 180 | |||
Gender (female) | -0.53 [-1.43-0.36] | 0.59 [0.24–1.44] | 0.24 |
Age (years) | 0.00 [-0.02-0.03] | 1.00 [0.98–1.03] | 0.77 |
Body weight (kg) | -0.23 [-0.47-0.02] | 0.80 [0.62–1.02] | 0.07 |
Height (cm) | 0.19 [-0.06-0.44] | 1.21 [0.94–1.56] | 0.14 |
Body mass index (kg/m2) | 0.7 [-0.05-1.45] | 2.01 [0.95–4.27] | 0.07 |
Days after start of COVID-19 symptoms | 0.00 [-0.01-0.01] | 1.00 [0.99–1.01] | 0.66 |
COVID-19 symptoms duration (days) | 0.00 [-0.03-0.04] | 1.00 [0.97–1.04] | 0.88 |
Abbott quantitative SARS-CoV-2 Ab test (100 BAU/ml) | 0.32 [0.22–0.43] | 1.38 [1.25–1.53] | < 0.001 |
Vaccination | 1.73 [0.56–2.9] | 5.66 [1.76–18.2] | 0.004 |